Keheala Chosen To Represent Israel At The 2019 World Summit Awards Awards, Competition, Innovation, LeadershipJon RathauserAugust 30, 2018Awards, Innovation, World Summit Awards, Impact, Positive Impact, Positive Change
In the year of TB, advocates want more than a political commitment Development Financing, Drug Resistance, Innovation, Leadership, Medical DevicesJon RathauserMarch 2, 2018TB, Tuberculosis, mHealth, Digital Health, WHO, Advocacy, diagnostics, Drug Compliance, Development Financing, Drug Resistance
KEHEALA HONORED WITH INNOVATION AWARDS Keheala's innovation was recently recognized with awards from Teva Pharmaceuticals and Nefesh B'Nefesh Read More Development Financing, Innovation, Leadership, AwardsJon RathauserJanuary 23, 2018Innovation, Teva, Awards, Prize, Competition, Pharmaceuticals, Venture funding
Keheala Announces Investment by Check Point Software Technologies Co-Founder, Marius Nacht Development Financing, Drug Resistance, Innovation, LeadershipJon RathauserJanuary 4, 2018Marius Nacht, Checkpoint, Investment, Development Financing, USAID, U.S. Agency for International Development, Unit 8200, Jon Rathauser, aMoon Fund, Behavioral Interventions, behavior change, disease, Infectious Disease, chronic disease, kenya, financing, innovation
Improved Diagnostics Fail to Halt the Rise of Tuberculosis Medical Devices, Leadership, Innovation, Evidence, Development Financing, Drug ResistanceJon RathauserNovember 18, 2017diagnostics, tb, Development Financing, Social Interventions
"Pandemic alert: Tuberculosis is world's No. 1 infectious killer" - CNBC Development Financing, Drug Resistance, Leadership, Medical Devices, Lifestyle, Innovation, EvidenceJon RathauserOctober 30, 2017tuberculosis, TB, Treatment, MDR TB, Drug Resistance, multidrug resistant TB, WHO, World Health Organization, Infectious Disease
Keheala's CEO & Founder, Jon Rathauser, discusses Keheala with JNF Innovation, Lifestyle, LeadershipJon RathauserSeptember 28, 2017Jon Rathauser, Israel, Keheala, Lacrosse, Kenya, Leadership, Lifestyle, Podcasts, Technion, Israel Lacrosse, tuberculosis, TB, HIV, Non-adherence